We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$182M
AUM Growth
+$5.66M
Cap. Flow
+$6.44M
Cap. Flow %
3.54%
Top 10 Hldgs %
47.84%
Holding
149
New
20
Increased
31
Reduced
12
Closed
15

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.02M
2
WPZ
Williams Partners L.P.
WPZ
+$1.23M
3
KYN icon
Kayne Anderson Energy Infrastructure Fund
KYN
+$1M
4
MWE
MARKWEST ENERGY PARTNERS, LP
MWE
+$679K
5
DFE icon
WisdomTree Europe SmallCap Dividend Fund
DFE
+$623K

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$2.18M
2
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$1.49M
3
AB icon
AllianceBernstein
AB
+$1.37M
4
IFF icon
International Flavors & Fragrances
IFF
+$546K
5
FWONA icon
Liberty Media Series A
FWONA
+$493K

Sector Composition

Rank Sector Weight
1 Energy 29.81%
2 Healthcare 27.11%
3 Financials 7.21%
4 Technology 3.88%
5 Materials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
126
Bank of America
BAC
$447B
$192K 0.11%
+11,234
New +$179K
FIG
127
DELISTED
Fortress Investment Group Llc
FIG
$158K 0.09%
22,975
– –
IWS icon
128
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$135K 0.07%
10,505
+63
+0.6% +$4.52K
IRD
129
Opus Genetics
IRD
$302M
$121K 0.07%
313
– –
CYHHZ
130
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$99K 0.05%
+3,949
New +$176
BCRX icon
131
BioCryst Pharmaceuticals
BCRX
$2.51B
$98K 0.05%
+10,000
New +$123K
DARE icon
132
Dare Bioscience
DARE
$20.4M
$84K 0.05%
167
– –
VIRX
133
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$79K 0.04%
52
– –
AB icon
134
AllianceBernstein
AB
$3.45B
– –
-53,000
Closed -$1.37M
COP icon
135
ConocoPhillips
COP
$148B
– –
-2,500
Closed -$214K
FCX icon
136
Freeport-McMoran
FCX
$98.7B
– –
-6,400
Closed -$233K
FLR icon
137
Fluor
FLR
$7.3B
– –
-2,770
Closed -$213K
FWDI
138
Forward Industries Inc
FWDI
$313M
– –
-1,232
Closed -$15K
GILD icon
139
Gilead Sciences
GILD
$165B
– –
-3,469
Closed -$287K
JCI icon
140
Johnson Controls International
JCI
$91.3B
– –
-4,106
Closed -$214K
LCTX icon
141
Lineage Cell Therapeutics
LCTX
$286M
– –
-156,425
Closed -$385K
MSFT icon
142
Microsoft
MSFT
$3.76T
– –
-10,600
Closed -$442K
OMCL icon
143
Omnicell
OMCL
$1.7B
– –
-7,000
Closed -$200K
SJM icon
144
J.M. Smucker
SJM
$12.6B
– –
-2,000
Closed -$213K
CTXS
145
DELISTED
Citrix Systems Inc
CTXS
– –
-4,527
Closed -$225K
MNK
146
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-2,600
Closed -$208K
NQM
147
DELISTED
NUVEEN INVESTMENT QLTY MUNI FD
NQM
– –
-22,700
Closed -$333K
TYC
148
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
– –
-6,891
Closed -$329K
2 3 4 5
6

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q3 2014 Portfolio in Review

As of Q3 2014, Northeast Financial Consultants held 149 positions worth $182M, up 3.2% from $177M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Northeast Financial Consultants deployed $6.44M of net new capital in Q3 2014, opening 20 new positions and adding to 31 existing holdings. Its largest new stake was Williams Partners L.P.: 20,796 shares worth $1.25M.

By sector, the portfolio is most concentrated in Energy at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Magellan Midstream Partners, L.P., an estimated $2.18M trimmed.

  • Northeast Financial Consultants's largest Q3 2014 buy was Williams Partners L.P.: 20,796 shares worth $1.25M.
  • Northeast Financial Consultants added most to Pfizer in Q3 2014, an estimated $3.02M increase.
  • Northeast Financial Consultants's biggest Q3 2014 reduction was Magellan Midstream Partners, L.P., cutting an estimated $2.18M.
  • Northeast Financial Consultants fully exited AllianceBernstein in Q3 2014, selling an estimated $1.37M.
  • Northeast Financial Consultants's ten largest holdings make up 48% of its $182M portfolio in Q3 2014.
  • Northeast Financial Consultants opened 20 new positions and closed 15 in Q3 2014.
  • Northeast Financial Consultants's portfolio value rose 3.2% quarter-over-quarter to $182M.

Based on Northeast Financial Consultants's 13F filing for Q3 2014, filed 12 Nov 2014.